A Preliminary, Non-comparative Study to Evaluate a Bioresorbable Wound Scaffold in Acute Wounds

NCT ID: NCT01081522

Last Updated: 2010-03-05

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

12 participants

Study Classification

OBSERVATIONAL

Study Start Date

2009-10-31

Study Completion Date

2010-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

As this is a proof-of-concept study, the primary objective is to provide preliminary data on the safety and efficacy of Bioresorbable Wound Scaffold in the management of acute wounds left to heal by secondary intent.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pilonidal Sinus

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Subjects over 18 years, willing and able to provide written informed consent.
* Subjects who have an excised pilonidal sinus wound left to heal by secondary intent.
* Subjects who are willing to commit to having two biopsies being taken during the study.

Exclusion Criteria

* Subjects with a history of skin sensitivity to any of the components of the study product
* Subjects whose wound is infected
* Subjects who have participated in a previous clinical study within the past 3 months
* Subjects' with a known history of poor compliance with medical treatments
* Subjects who are pregnant (where pregnancy is a possibility, a pregnancy testing kit will be provided)
* Necrotic/sloughy wounds unless surgically debrided prior to enrolment
* Medical or emotional risk associated with the potential biopsy that outweighs the risk of not taking a biopsy as determined by the investigator
* Subjects exhibiting any other medical condition which, according to the Investigator, justifies the subject's exclusion from the study
* Subjects with impaired renal function
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

ConvaTec Inc.

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Convatec Inc.

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Dheerendra Kommala, MD

Role: STUDY_DIRECTOR

ConvaTec Inc.

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hillerod Hospital

Hillerød, Dk 3400, Denmark

Site Status

Wound Healing Research Unit

Heathpark, Cardiff, United Kingdom

Site Status

Scunthorpe General Hospital

Scunthorpe, North Lincolnshire, United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Denmark United Kingdom

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CW-0510-09-U352

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Derma-Stent Novel Abscess Packing Device
NCT03171714 UNKNOWN PHASE1/PHASE2